ArticleAnnals of clinical and translational neurology2020

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma.

Thomas J Kaley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.